{"id":"W4382025379","doi":"10.1093/bjd/ljad113.366","title":"PS14 Bimekizumab response up to 3 years in patients with moderate-to-severe plaque psoriasis who responded at week 16: post hoc results from the BE BRIGHT open-label extension trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Dermatology Life Quality Index; Medicine; Plaque psoriasis; Psoriasis Area and Severity Index; Psoriasis; Quality of life (healthcare); Open label; Randomized controlled trial; Internal medicine; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002975307,0.0008249965,0.0019076,0.0002275765,0.0004062825,0.001146975,0.0005057392,0.000825265,0.004190424],"category_scores_gemma":[0.001597839,0.0003914444,0.002057464,0.000286602,0.000595585,0.000988191,0.0005487541,0.002537092,0.0009262445],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005069847,"about_ca_system_score_gemma":0.001064034,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005875945,"about_ca_topic_score_gemma":0.001322839,"domain_scores_codex":[0.9990515,0.0005512671,0.00003771846,0.0001076242,0.00008073483,0.0001711102],"domain_scores_gemma":[0.9988715,0.0002741261,0.0002474367,0.0001241185,0.0000856916,0.0003970389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9620196,0.007758789,0.004948367,0.0002449545,0.0009976214,0.0000458207,0.00007166214,0.0004349282,0.003455829,0.00007442734,0.001640177,0.01830783],"study_design_scores_gemma":[0.6121144,0.3235017,0.05619593,0.00007381241,0.001838102,0.0001354261,0.0001094113,0.001060679,0.001380436,0.0003233656,0.003228178,0.00003853141],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946523,0.001442034,0.0001681352,0.0002730361,0.0001054336,0.0006963476,0.001063181,0.00003992544,0.00155953],"genre_scores_gemma":[0.9935456,0.0006886014,0.0003994428,0.0004543005,0.0002148878,0.001028741,0.001823205,0.00001475504,0.001830496],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004190424,"threshold_uncertainty_score":0.01573509,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02786197286823874,"score_gpt":0.2572829078364869,"score_spread":0.2294209349682482,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}